1. Home
  2. PURR vs QURE Comparison

PURR vs QURE Comparison

Compare PURR & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PURR

Hyperliquid Strategies Inc

N/A

Current Price

$4.89

Market Cap

576.4M

Sector

Health Care

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$14.73

Market Cap

663.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PURR
QURE
Founded
2025
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.4M
663.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PURR
QURE
Price
$4.89
$14.73
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$7.23
$44.92
AVG Volume (30 Days)
5.2M
4.6M
Earning Date
05-12-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$126.12
Revenue Next Year
$148.78
$210.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$7.76
52 Week High
$6.63
$71.50

Technical Indicators

Market Signals
Indicator
PURR
QURE
Relative Strength Index (RSI) 47.62 42.74
Support Level $3.27 $13.35
Resistance Level $5.78 $15.98
Average True Range (ATR) 0.56 1.43
MACD -0.11 0.28
Stochastic Oscillator 12.54 12.52

Price Performance

Historical Comparison
PURR
QURE

About PURR Hyperliquid Strategies Inc

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the largest HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to one of the largest and fastest growing revenue pools in digital assets.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: